|
USP24 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6278089987054E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64002145197628E-12 |
| Normal-vs-Stage2 |
9.77150000025517E-07 |
| Normal-vs-Stage3 |
7.92119999593055E-08 |
| Normal-vs-Stage4 |
1.010450E-04 |
| Stage1-vs-Stage2 |
6.104600E-01 |
| Stage1-vs-Stage3 |
8.256400E-01 |
| Stage1-vs-Stage4 |
7.581600E-01 |
| Stage2-vs-Stage3 |
8.018600E-01 |
| Stage2-vs-Stage4 |
9.511800E-01 |
| Stage3-vs-Stage4 |
8.900600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
6.38120001283937E-10 |
| Normal-vs-Asian |
1.961630E-04 |
| Caucasian-vs-AfricanAmerican |
4.714800E-01 |
| Caucasian-vs-Asian |
6.444400E-01 |
| AfricanAmerican-vs-Asian |
5.153400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
1.72475999999921E-05 |
| Male-vs-Female |
1.341340E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.21539997458109E-09 |
| Normal-vs-Extreme_Weight |
1.62492241884138E-12 |
| Normal-vs-Obese |
5.18279974492941E-10 |
| Normal-vs-Extreme_Obese |
2.241700E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.601020E-01 |
| Normal_Weight-vs-Obese |
5.699000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.763600E-01 |
| Extreme_Weight-vs-Obese |
2.283600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.886600E-01 |
| Obese-vs-Extreme_Obese |
7.225600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.322120E-03 |
| Normal-vs-Age(41-60Yrs) |
1.05659925253576E-11 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.19620000016418E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.950200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.923700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.415800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.838200E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.625600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.749400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
8.20565837500453E-13 |
| Normal-VS-KIRP CIMP |
6.109800E-02 |
| Normal-VS-Unclassified PRCC |
8.3370000014682E-08 |
| Type1 PRCC-VS-Type2 PRCC |
5.095000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.991600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.859000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.139300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.102200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.951700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.33250077638536E-11 |
| Normal-vs-N1 |
7.65390000000421E-05 |
| Normal-vs-N2 |
2.186200E-02 |
| N0-vs-N1 |
1.525840E-02 |
| N0-vs-N2 |
1.427370E-01 |
| N1-vs-N2 |
8.468800E-01 |
|
|
